tiprankstipranks
Moleculin Biotech (MBRX)
NASDAQ:MBRX
US Market

Moleculin Biotech (MBRX) Income Statement

Compare
1,462 Followers

Moleculin Biotech Income Statement

Last quarter (Q3 2024), Moleculin Biotech's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Moleculin Biotech's net income was $-10.59M. See Moleculin Biotech’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -127.00K$ -222.00K$ -260.00K$ -285.00K$ -185.00K
Operating Expenses
$ 29.63M$ 30.64M$ 22.97M$ 19.74M$ 17.52M
Depreciation and Amortization
$ 127.00K$ 222.00K$ 260.00K$ 285.00K$ 185.00K
EBITDA
$ -29.50M$ -30.51M$ -22.80M$ -19.54M$ -13.25M
Operating Income
$ -29.63M$ -30.64M$ -22.97M$ -19.74M$ -17.52M
Other Income/Expenses
$ -138.00K$ 1.61M$ 7.07M$ 2.39M$ 4.09M
Pretax Income
$ -29.77M$ -29.02M$ -15.89M$ -17.36M$ -13.43M
Net Income
$ -29.77M$ -27.41M$ -8.86M$ -15.00M$ -13.21M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -15.07$ -14.37$ -4.94$ -22.85$ -29.18
Diluted EPS
$ -15.07$ -14.37$ -4.94$ -22.85$ -29.18
Weighted Average Shares Outstanding
1.98M 1.91M 1.79M 656.38K 452.46K
Weighted Average Shares Outstanding (Diluted)
1.98M 1.91M 1.79M 656.38K 452.46K
Currency in USD

Moleculin Biotech Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis